TOKYO, Oct 16 (Reuters) - Fujifilm Holdings Corp
said on Friday it had applied for approval in Japan of its
anti-influenza drug Avigan as a treatment for COVID-19.
The company had said in September a late-stage study of
Avigan had shown reduced recovery times for COVID-19 patients
with non-severe symptoms and it would seek to file for approval
as early as this month.
(Reporting by Chris Gallagher; Editing by Muralikumar